Slowed reaction time in HIV-1-seropositive intravenous drug users without AIDS

European Neurology

Volumn 44, Issue 2, 2000, Pages 72-78

  Ayuso Mateos, J L ^a,b   Pereda, M ^a   Gomez Del Barrio A ^a   Echevarria, S ^a   Farinas M C ^a   Garcia Palomo D ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Human immunodeficiency virus; Reaction time; Substance abuse

Indexed keywords

ADULT; AGE; ARTICLE; AUTOMATION; COGNITION; COVARIANCE; EDUCATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MOTOR RETARDATION; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PRIORITY JOURNAL; RATING SCALE; REACTION TIME; SCORING SYSTEM; SERODIAGNOSIS;

EID: 0033798324     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008200     Document Type: Article

References (28)

1. Perdices M, Cooper DA: Simple and choice reaction time in patients with human immunodeficiency virus infection. Ann Neurol 1989; 25:460-467.
2. Jakobsen J, Gyldensted C, Brun B, Bruhn P, Helweg-Larsen S, Arlien-Soborg P: Cerebral ventricular enlargement relates to neuropsychological measures in unselected AIDS patients. Acta Neurol Scand 1989;79:59-62.
3. Karlsen NR, Reinvang I, Froland SS: Slowed reaction time in asymptomatic HIV-positive patients. Acta Neurol Scand 1992;86:242-246.
4. Dunlop O, Bjorklund RA, Abdelnoor M, Myrvang B: Five different tests of reaction time evaluated in HIV seropositive men. Acta Neurol Scand 1992;86:260-266.
5. Martin EM, Sorensen DJ, Edelstein HE, Robertson LC: Decision-making speed in HIV infection: A preliminary report. AIDS 1992;6: 109-113.
6. Wilkie FL, Eisdorfer C, Morgan R, Loewenstein DA, Szapocznik J: Cognition in early human immunodeficiency virus infection. Arch Neurol 1990;47:433-440.
7. Miller EN, Satz P, Visscher B: Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology 1991;41:1608-1616.
8. Starace F, Baldassarre C, Biancolilli V, Fea M, Serpelloni G, Bartoli L, Maj M: Early neuropsychological impairment in HIV-seropositive intravenous drug users: Evidence from the Italian Multicentre Neuropsychological HIV Study. Acta Psychiatr Scand 1998;97:132-138.
9. Royal W, Updike M, Selnes OA, Proctor TV, Nance-Sproson L, Solomon L, Vlahov D, Cornblath DR, McArthur JC: HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991;41:1905-1910.
10. Egan V, Brettle RP, Goodwin GM: The Edinburgh cohort of HIV-positive drug users: Pattern of cognitive impairment in relation to progression of disease. Br J Neurol 1992;161:522-531.
11. Grassi MP, Perin C, Clerici F, Zocchetti C, Cargnel A, Mangoni A: Neuropsychological performance in HIV-1-infected drug users. Acta Neurol Scand 1993;88:119-122.
12. Rodriguez Salgado D, Rodriguez Álvarez M: Vulnerabilidad neuropsicológica de los drogodependientes a la infección por VIH-1. Rev Esp Drogodepend 1997;22:203-218.
13. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MNWR 1992; 41:1-9.
14. Ancelle-Park R: European AIDS case definition. Lancet 1992;339:671.
15. Heseltine PNR, Goodkin K, Atkinson H, Vitiello B, Rochon J, Heaton RK, Eaton EM, Wilkie FL, Sobel E, Brown SJ, Feaster D, Schneider L, Goldschmidts WL, Stover ES: Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol 1998;55:41-51.
16. Pereda M, Ayuso-Mateos JL, Gómez del Barrio A, Echevarria S, Farinas MC, García Palomo D. González Macias J: Datos normativos para le exploración neuropsicológica de usuarios por vía parenteral. Actas Luso Esp Neurol Psiquiatr 1998;26:363-370.
17. Miller EN: California Computerized Assessment Package (CalCap). Los Angeles, Norland Software, 1986.
18. Wechsler D: WAIS Manual. New York, Psychological Corporation, 1955.
19. Butters N, Grant I, Haxby J, Judd LL, Martin A, McClelland J, Pequegnat W, Schacter D, Stover E: Assessment of AIDS-related cognitive changes: Recommendations of the NIMH workshop on neuropsychological assessment approaches. J Clin Exp Neuropsychol 1990;12: 963-978.
20. World Health Organization: Schedules for Clinical Assessment in Neuropsychiatry. Geneva, WHO, 1992.
21. World Health Organization. The tenth revision of the International Classification of Diseases and Related Health Problems. Geneva, WHO, 1992.
22. Montgomery S, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
23. Ollo C, Johnson R, Grafman J: Signs of cognitive change in HIV disease: An event related brain potential study. Neurology 1991;41:209-215.
24. Llorente AM, Miller EN, D'Elia LF, Selnes OA, Wesch J, Becker J, Satz P: Slowed information processing in HIV-1 disease. J Clin Exp Neuropsychol 1998;20:60-72.
25. Bornstein RA, Nasrallah HA, Para MF, et al: Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol 1991;48:704-707.
26. Baldeweg T, Catalan J, Lovett E, et al: Long-term zidovudine reduces neurocognitive deficits in HIV-infection. AIDS 1995;9:589-596.
27. Dunlop O, Bjorklund R, Bruun JN, et al: Longitudinal study of HIV positive men with tests of reaction time. Preliminary results. Clin Neuropathol 1993;12(suppl 1):29.
28. Worth JL, Savage CR, Baer L, Esty EK, Navia BA: computer-based neuropsychological screening for AIDS dementia complex. AIDS 1993;7:677-681.